The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
Three drug companies dominate the U.S. insulin market: Novo Nordisk, Eli Lilly and Sanofi. Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk ...
The PACEO, established in March 2024, is a controlled financing solution pending revenues from BioChaperone Lispro and the ...
Earlier this year, Eli Lilly reported temporary shortages of Humalog and insulin lispro in 10-milliliter ... reported shortages of NovoLog insulin. Drug companies recommend patients check with ...